-
1
-
-
0037135111
-
The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
-
Hardy J, Selkoe DJ,. 2002. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297 (5580): 353-356.
-
(2002)
Science
, vol.297
, Issue.5580
, pp. 353-356
-
-
Hardy, J.1
Selkoe, D.J.2
-
2
-
-
84897569558
-
Alzheimer's disease research in the future: Bibliometric analysis of cholinesterase inhibitors from 1993 to 2012
-
Chen H, Wan Y, Jiang S, Cheng Y,. 2013. Alzheimer's disease research in the future: Bibliometric analysis of cholinesterase inhibitors from 1993 to 2012. Scientometrics 98 (3): 1865-1877.
-
(2013)
Scientometrics
, vol.98
, Issue.3
, pp. 1865-1877
-
-
Chen, H.1
Wan, Y.2
Jiang, S.3
Cheng, Y.4
-
3
-
-
34547667531
-
Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics
-
Cacabelos R,. 2007. Donepezil in Alzheimer's disease: From conventional trials to pharmacogenetics. Neuropsychiatr Dis Treat 3 (3): 303-333.
-
(2007)
Neuropsychiatr Dis Treat
, vol.3
, Issue.3
, pp. 303-333
-
-
Cacabelos, R.1
-
4
-
-
0019972810
-
The cholinergic hypothesis of geriatric memory dysfunction
-
Bartus RT, Dean RL 3rd, Beer B, Lippa AS,. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217 (4558): 408-414.
-
(1982)
Science
, vol.217
, Issue.4558
, pp. 408-414
-
-
Bartus, R.T.1
Dean III, R.L.2
Beer, B.3
Lippa, A.S.4
-
5
-
-
47849119964
-
Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: A systematic review and meta-analysis
-
Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE,. 2008. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: A systematic review and meta-analysis. Clin Interv Aging 3 (2): 211-225.
-
(2008)
Clin Interv Aging
, vol.3
, Issue.2
, pp. 211-225
-
-
Hansen, R.A.1
Gartlehner, G.2
Webb, A.P.3
Morgan, L.C.4
Moore, C.G.5
Jonas, D.E.6
-
6
-
-
0030879494
-
Donepezil (E2020): A new acetylcholinesterase inhibitor. Review of its pharmacology, pharmacokinetics, and utility in the treatment of Alzheimer's disease
-
Heydorn WE,. 1997. Donepezil (E2020): A new acetylcholinesterase inhibitor. Review of its pharmacology, pharmacokinetics, and utility in the treatment of Alzheimer's disease. Expert Opin Investig Drugs 6 (10): 1527-1535.
-
(1997)
Expert Opin Investig Drugs
, vol.6
, Issue.10
, pp. 1527-1535
-
-
Heydorn, W.E.1
-
7
-
-
0032439162
-
Cholinesterase inhibitors in the treatment of Alzheimer's disease: A comparison of tolerability and pharmacology
-
Nordberg A, Svensson AL,. 1998. Cholinesterase inhibitors in the treatment of Alzheimer's disease: A comparison of tolerability and pharmacology. Drug Saf 19 (6): 465-480.
-
(1998)
Drug Saf
, vol.19
, Issue.6
, pp. 465-480
-
-
Nordberg, A.1
Svensson, A.L.2
-
8
-
-
0035012753
-
Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease
-
Imbimbo BP,. 2001. Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease. CNS Drugs 15 (5): 375-390.
-
(2001)
CNS Drugs
, vol.15
, Issue.5
, pp. 375-390
-
-
Imbimbo, B.P.1
-
9
-
-
0036349129
-
Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors
-
Jann MW, Shirley KL, Small GW,. 2002. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors. Clin Pharmacokinet 41 (10): 719-739.
-
(2002)
Clin Pharmacokinet
, vol.41
, Issue.10
, pp. 719-739
-
-
Jann, M.W.1
Shirley, K.L.2
Small, G.W.3
-
10
-
-
64149090366
-
Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: A review
-
Kurz A, Farlow M, Lefevre G,. 2009. Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: A review. Int J Clin Pract 63 (5): 799-805.
-
(2009)
Int J Clin Pract
, vol.63
, Issue.5
, pp. 799-805
-
-
Kurz, A.1
Farlow, M.2
Lefevre, G.3
-
11
-
-
0032424681
-
Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses
-
Rogers SL, Cooper NM, Sukovaty R, Pederson JE, Lee JN, Friedhoff LT,. 1998. Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses. Br J Clin Pharmacol 46 Suppl 1: 7-12.
-
(1998)
Br J Clin Pharmacol
, vol.46
, Issue.SUPPL. 1
, pp. 7-12
-
-
Rogers, S.L.1
Cooper, N.M.2
Sukovaty, R.3
Pederson, J.E.4
Lee, J.N.5
Friedhoff, L.T.6
-
12
-
-
33846317458
-
In vitro and in vivo evaluation of donepezil-sustained release microparticles for the treatment of Alzheimer's disease
-
Zhang P, Chen L, Gu W, Xu Z, Gao Y, Li Y,. 2007. In vitro and in vivo evaluation of donepezil-sustained release microparticles for the treatment of Alzheimer's disease. Biomaterials 28 (10): 1882-1888.
-
(2007)
Biomaterials
, vol.28
, Issue.10
, pp. 1882-1888
-
-
Zhang, P.1
Chen, L.2
Gu, W.3
Xu, Z.4
Gao, Y.5
Li, Y.6
-
13
-
-
84655176478
-
Effect of fatty acids on the transdermal delivery of donepezil: In vitro and in vivo evaluation
-
Choi J, Choi MK, Chong S, Chung SJ, Shim CK, Kim DD,. 2012. Effect of fatty acids on the transdermal delivery of donepezil: In vitro and in vivo evaluation. Int J Pharm 422 (1-2): 83-90.
-
(2012)
Int J Pharm
, vol.422
, Issue.12
, pp. 83-90
-
-
Choi, J.1
Choi, M.K.2
Chong, S.3
Chung, S.J.4
Shim, C.K.5
Kim, D.D.6
-
14
-
-
84862081912
-
Recent developments in buccal and sublingual delivery systems
-
Senel S, Rathbone MJ, Cansiz M, Pather I,. 2012. Recent developments in buccal and sublingual delivery systems. Expert Opin Drug Deliv 9 (6): 615-628.
-
(2012)
Expert Opin Drug Deliv
, vol.9
, Issue.6
, pp. 615-628
-
-
Senel, S.1
Rathbone, M.J.2
Cansiz, M.3
Pather, I.4
-
15
-
-
33746468534
-
Buccal bioadhesive drug delivery - A promising option for orally less efficient drugs
-
Sudhakar Y, Kuotsu K, Bandyopadhyay AK,. 2006. Buccal bioadhesive drug delivery-A promising option for orally less efficient drugs. J Control Release 114 (1): 15-40.
-
(2006)
J Control Release
, vol.114
, Issue.1
, pp. 15-40
-
-
Sudhakar, Y.1
Kuotsu, K.2
Bandyopadhyay, A.K.3
-
16
-
-
0017033158
-
The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water
-
Galey WR, Lonsdale HK, Nacht S,. 1976. The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water. J Invest Dermatol 67 (6): 713-717.
-
(1976)
J Invest Dermatol
, vol.67
, Issue.6
, pp. 713-717
-
-
Galey, W.R.1
Lonsdale, H.K.2
Nacht, S.3
-
17
-
-
1842453883
-
Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones
-
Di Angelantonio S, Bernardi G, Mercuri NB,. 2004. Donepezil modulates nicotinic receptors of substantia nigra dopaminergic neurones. Br J Pharmacol 141 (4): 644-652.
-
(2004)
Br J Pharmacol
, vol.141
, Issue.4
, pp. 644-652
-
-
Di Angelantonio, S.1
Bernardi, G.2
Mercuri, N.B.3
-
18
-
-
0842267696
-
Assessment of the effects of sodium dodecyl sulfate on the buccal permeability of caffeine and estradiol
-
Nicolazzo JA, Reed BL, Finnin BC,. 2004. Assessment of the effects of sodium dodecyl sulfate on the buccal permeability of caffeine and estradiol. J Pharm Sci 93 (2): 431-440.
-
(2004)
J Pharm Sci
, vol.93
, Issue.2
, pp. 431-440
-
-
Nicolazzo, J.A.1
Reed, B.L.2
Finnin, B.C.3
-
19
-
-
21744461452
-
Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide
-
Nicolazzo JA, Reed BL, Finnin BC,. 2005. Enhancing the buccal mucosal uptake and retention of triamcinolone acetonide. J Control Release 105 (3): 240-248.
-
(2005)
J Control Release
, vol.105
, Issue.3
, pp. 240-248
-
-
Nicolazzo, J.A.1
Reed, B.L.2
Finnin, B.C.3
-
20
-
-
78149339756
-
The buccal mucosa as an alternative route for the systemic delivery of risperidone
-
Heemstra LB, Finnin BC, Nicolazzo JA,. 2010. The buccal mucosa as an alternative route for the systemic delivery of risperidone. J Pharm Sci 99 (11): 4584-4592.
-
(2010)
J Pharm Sci
, vol.99
, Issue.11
, pp. 4584-4592
-
-
Heemstra, L.B.1
Finnin, B.C.2
Nicolazzo, J.A.3
-
21
-
-
0003484310
-
-
FDA. 1 ed. Accessed, at.
-
FDA. 2001. Guidance for industry: Bioanalytical method validation. 1 ed. Accessed, at: http://www.fda.gov/downloads/ DrugsGuidanceComplianceRegulatory%20Information/Guidances/UCM070107.pdf.
-
(2001)
Guidance for Industry: Bioanalytical Method Validation
-
-
-
23
-
-
34250744722
-
Central nervous system drug disposition: The relationship between in situ brain permeability and brain free fraction
-
Summerfield SG, Read K, Begley DJ, Obradovic T, Hidalgo IJ, Coggon S, Lewis AV, Porter RA, Jeffrey P,. 2007. Central nervous system drug disposition: The relationship between in situ brain permeability and brain free fraction. J Pharmacol Exp Ther 322 (1): 205-213.
-
(2007)
J Pharmacol Exp Ther
, vol.322
, Issue.1
, pp. 205-213
-
-
Summerfield, S.G.1
Read, K.2
Begley, D.J.3
Obradovic, T.4
Hidalgo, I.J.5
Coggon, S.6
Lewis, A.V.7
Porter, R.A.8
Jeffrey, P.9
-
24
-
-
0021739393
-
Physicochemical properties of bile acids and their relationship to biological properties: An overview of the problem
-
Hofmann AF, Roda A,. 1984. Physicochemical properties of bile acids and their relationship to biological properties: An overview of the problem. J Lipid Res 25 (13): 1477-1489.
-
(1984)
J Lipid Res
, vol.25
, Issue.13
, pp. 1477-1489
-
-
Hofmann, A.F.1
Roda, A.2
-
25
-
-
0027141935
-
Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects
-
Ohnishi A, Mihara M, Kamakura H, Tomono Y, Hasegawa J, Yamazaki K, Morishita N, Tanaka T,. 1993. Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects. J Clin Pharmacol 33 (11): 1086-1091.
-
(1993)
J Clin Pharmacol
, vol.33
, Issue.11
, pp. 1086-1091
-
-
Ohnishi, A.1
Mihara, M.2
Kamakura, H.3
Tomono, Y.4
Hasegawa, J.5
Yamazaki, K.6
Morishita, N.7
Tanaka, T.8
-
26
-
-
84866542855
-
Transdermal donepezil on the treatment of Alzheimer's disease
-
Sozio P, Cerasa LS, Marinelli L, Di Stefano A,. 2012. Transdermal donepezil on the treatment of Alzheimer's disease. Neuropsychiatr Dis Treat 8: 361-368.
-
(2012)
Neuropsychiatr Dis Treat
, vol.8
, pp. 361-368
-
-
Sozio, P.1
Cerasa, L.S.2
Marinelli, L.3
Di Stefano, A.4
-
27
-
-
53849141376
-
Effect of thermodynamic activities of the unionized and ionized species on drug flux across buccal mucosa
-
Kokate A, Li X, Singh P, Jasti BR,. 2008. Effect of thermodynamic activities of the unionized and ionized species on drug flux across buccal mucosa. J Pharm Sci 97 (10): 4294-4306.
-
(2008)
J Pharm Sci
, vol.97
, Issue.10
, pp. 4294-4306
-
-
Kokate, A.1
Li, X.2
Singh, P.3
Jasti, B.R.4
-
28
-
-
12244305575
-
Buccal permeation of buspirone: Mechanistic studies on transport pathways
-
Birudaraj R, Berner B, Shen S, Li X,. 2005. Buccal permeation of buspirone: Mechanistic studies on transport pathways. J Pharm Sci 94 (1): 70-78.
-
(2005)
J Pharm Sci
, vol.94
, Issue.1
, pp. 70-78
-
-
Birudaraj, R.1
Berner, B.2
Shen, S.3
Li, X.4
-
29
-
-
84892633112
-
First-in-human phase i study of PRS-050 (Angiocal), an anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors
-
Mross K, Richly H, Fischer R, Scharr D, Buchert M, Stern A, Gille H, Audoly LP, Scheulen ME,. 2013. First-in-human phase I study of PRS-050 (Angiocal), an anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors. PLoS One 8 (12): e83232.
-
(2013)
PLoS One
, vol.8
, Issue.12
-
-
Mross, K.1
Richly, H.2
Fischer, R.3
Scharr, D.4
Buchert, M.5
Stern, A.6
Gille, H.7
Audoly, L.P.8
Scheulen, M.E.9
-
30
-
-
0032507788
-
Donepezil improves cognition and global function in Alzheimer disease: A 15-week, double-blind, placebo-controlled study. Donepezil study group
-
Rogers SL, Doody RS, Mohs RC, Friedhoff LT,. 1998. Donepezil improves cognition and global function in Alzheimer disease: A 15-week, double-blind, placebo-controlled study. Donepezil study group. Arch Intern Med 158 (9): 1021-1031.
-
(1998)
Arch Intern Med
, vol.158
, Issue.9
, pp. 1021-1031
-
-
Rogers, S.L.1
Doody, R.S.2
Mohs, R.C.3
Friedhoff, L.T.4
-
31
-
-
20444371579
-
Buccal penetration enhancers - How do they really work
-
Nicolazzo JA, Reed BL, Finnin BC,. 2005. Buccal penetration enhancers-How do they really work ? J Control Release 105 (1-2): 1-15.
-
(2005)
J Control Release
, vol.105
, Issue.12
, pp. 1-15
-
-
Nicolazzo, J.A.1
Reed, B.L.2
Finnin, B.C.3
-
32
-
-
84864851442
-
Azone analogues: Classification, design, and transdermal penetration principles
-
Jampilek J, Brychtova K,. 2012. Azone analogues: Classification, design, and transdermal penetration principles. Med Res Rev 32 (5): 907-947.
-
(2012)
Med Res Rev
, vol.32
, Issue.5
, pp. 907-947
-
-
Jampilek, J.1
Brychtova, K.2
-
33
-
-
0027456749
-
In vitro evaluation of a series of Azone analogs as dermal penetration enhancers. i
-
Michniak BB, Player MR, Chapman Jr JM, Sowell Sr JW,. 1993. In vitro evaluation of a series of Azone analogs as dermal penetration enhancers. I. Int J Pharm 91 (1): 85-93.
-
(1993)
Int J Pharm
, vol.91
, Issue.1
, pp. 85-93
-
-
Michniak, B.B.1
Player, M.R.2
Chapman Jr., J.M.3
Sowell, Sr.J.W.4
-
34
-
-
0037311323
-
Mechanistic study of alkyl azacycloheptanones as skin permeation enhancers by permeation and partition experiments with hairless mouse skin
-
He N, Li SK, Marjukka Suhonen T, Warner KS, Higuchi WI,. 2003. Mechanistic study of alkyl azacycloheptanones as skin permeation enhancers by permeation and partition experiments with hairless mouse skin. J Pharm Sci 92 (2): 297-310.
-
(2003)
J Pharm Sci
, vol.92
, Issue.2
, pp. 297-310
-
-
He, N.1
Li, S.K.2
Marjukka Suhonen, T.3
Warner, K.S.4
Higuchi, W.I.5
-
35
-
-
3843104844
-
Modification of buccal drug delivery following pretreatment with skin penetration enhancers
-
Nicolazzo JA, Reed BL, Finnin BC,. 2004. Modification of buccal drug delivery following pretreatment with skin penetration enhancers. J Pharm Sci 93 (8): 2054-2063.
-
(2004)
J Pharm Sci
, vol.93
, Issue.8
, pp. 2054-2063
-
-
Nicolazzo, J.A.1
Reed, B.L.2
Finnin, B.C.3
-
36
-
-
0037043077
-
Buccal transport of flecainide and sotalol: Effect of a bile salt and ionization state
-
Deneer VH, Drese GB, Roemele PE, Verhoef JC, Lie AHL, Kingma JH, Brouwers JR, Junginger HE,. 2002. Buccal transport of flecainide and sotalol: Effect of a bile salt and ionization state. Int J Pharm 241 (1): 127-134.
-
(2002)
Int J Pharm
, vol.241
, Issue.1
, pp. 127-134
-
-
Deneer, V.H.1
Drese, G.B.2
Roemele, P.E.3
Verhoef, J.C.4
Lie, A.H.L.5
Kingma, J.H.6
Brouwers, J.R.7
Junginger, H.E.8
-
37
-
-
34547126907
-
Transbuccal delivery of 5-aza-2 -deoxycytidine: Effects of drug concentration, buffer solution, and bile salts on permeation
-
Mahalingam R, Ravivarapu H, Redkar S, Li X, Jasti BR,. 2007. Transbuccal delivery of 5-aza-2 -deoxycytidine: Effects of drug concentration, buffer solution, and bile salts on permeation. AAPS PharmSciTech 8 (3): E55.
-
(2007)
AAPS PharmSciTech
, vol.8
, Issue.3
-
-
Mahalingam, R.1
Ravivarapu, H.2
Redkar, S.3
Li, X.4
Jasti, B.R.5
-
38
-
-
0028020206
-
Enhancement of in vitro permeability of porcine buccal mucosa by bile salts: Kinetic and histological studies
-
Boddé HE,. 1994. Enhancement of in vitro permeability of porcine buccal mucosa by bile salts: Kinetic and histological studies. J Control Release 32 (1): 45-56.
-
(1994)
J Control Release
, vol.32
, Issue.1
, pp. 45-56
-
-
Boddé, H.E.1
-
39
-
-
80052856585
-
Effects of bile salts on glucosylceramide containing membranes
-
Halin J, Mattjus P,. 2011. Effects of bile salts on glucosylceramide containing membranes. Biochim Biophys Acta 1808 (12): 2886-2893.
-
(2011)
Biochim Biophys Acta
, vol.1808
, Issue.12
, pp. 2886-2893
-
-
Halin, J.1
Mattjus, P.2
-
40
-
-
84861593280
-
Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: The effect of PEG-400 on carbamazepine absorption
-
Beig A, Miller JM, Dahan A,. 2012. Accounting for the solubility-permeability interplay in oral formulation development for poor water solubility drugs: The effect of PEG-400 on carbamazepine absorption. Eur J Pharm Biopharm 81 (2): 386-391.
-
(2012)
Eur J Pharm Biopharm
, vol.81
, Issue.2
, pp. 386-391
-
-
Beig, A.1
Miller, J.M.2
Dahan, A.3
-
41
-
-
0036744917
-
Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine
-
Basit A, Podczeck F, Newton JM, Waddington W, Ell P, Lacey L,. 2002. Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidine. Pharm Res 19 (9): 1368-1374.
-
(2002)
Pharm Res
, vol.19
, Issue.9
, pp. 1368-1374
-
-
Basit, A.1
Podczeck, F.2
Newton, J.M.3
Waddington, W.4
Ell, P.5
Lacey, L.6
-
42
-
-
51649123932
-
Polyethylene glycol 400 enhances the bioavailability of a BCS class III drug (ranitidine) in male subjects but not females
-
Ashiru DAI, Patel R, Basit AW,. 2008. Polyethylene glycol 400 enhances the bioavailability of a BCS class III drug (ranitidine) in male subjects but not females. Pharm Res 25 (10): 2327-2333.
-
(2008)
Pharm Res
, vol.25
, Issue.10
, pp. 2327-2333
-
-
Ashiru, D.A.I.1
Patel, R.2
Basit, A.W.3
-
43
-
-
0021277372
-
Long-term skin permeation kinetics of estradiol (I): Effect of drug solubilizer-polyethylene glycol 400
-
Valia KH, Chien YW, Shinal EC,. 1984. Long-term skin permeation kinetics of estradiol (I): Effect of drug solubilizer-polyethylene glycol 400. Drug Dev Ind Pharm 10 (7): 951-981.
-
(1984)
Drug Dev Ind Pharm
, vol.10
, Issue.7
, pp. 951-981
-
-
Valia, K.H.1
Chien, Y.W.2
Shinal, E.C.3
-
44
-
-
84861092809
-
The influence of the polar head and the hydrophobic chain on the skin penetration enhancement effect of poly(ethylene glycol) derivatives
-
Casiraghi A, Di Grigoli M, Cilurzo F, Gennari CGM, Rossoni G, Minghetti P,. 2012. The influence of the polar head and the hydrophobic chain on the skin penetration enhancement effect of poly(ethylene glycol) derivatives. AAPS PharmSciTech 13 (1): 247-253.
-
(2012)
AAPS PharmSciTech
, vol.13
, Issue.1
, pp. 247-253
-
-
Casiraghi, A.1
Di Grigoli, M.2
Cilurzo, F.3
Gennari, C.G.M.4
Rossoni, G.5
Minghetti, P.6
-
45
-
-
0025903574
-
Effect of polyethylene glycol 400 on the intestinal permeability of carbamazepine in the rabbit
-
Riad L, Sawchuk R,. 1991. Effect of polyethylene glycol 400 on the intestinal permeability of carbamazepine in the rabbit. Pharm Res 8 (4): 491-497.
-
(1991)
Pharm Res
, vol.8
, Issue.4
, pp. 491-497
-
-
Riad, L.1
Sawchuk, R.2
-
46
-
-
84863229573
-
The solubility-permeability interplay when using cosolvents for solubilization: Revising the way we use solubility-enabling formulations
-
Miller JM, Beig A, Carr RA, Webster GK, Dahan A,. 2012. The solubility-permeability interplay when using cosolvents for solubilization: Revising the way we use solubility-enabling formulations. Mol Pharm 9 (3): 581-590.
-
(2012)
Mol Pharm
, vol.9
, Issue.3
, pp. 581-590
-
-
Miller, J.M.1
Beig, A.2
Carr, R.A.3
Webster, G.K.4
Dahan, A.5
-
47
-
-
67549140838
-
Transbuccal delivery of 5-fluorouracil: Permeation enhancement and pharmacokinetic study
-
Dhiman MK, Dhiman A, Sawant KK,. 2009. Transbuccal delivery of 5-fluorouracil: Permeation enhancement and pharmacokinetic study. AAPS PharmSciTech 10 (1): 258-265.
-
(2009)
AAPS PharmSciTech
, vol.10
, Issue.1
, pp. 258-265
-
-
Dhiman, M.K.1
Dhiman, A.2
Sawant, K.K.3
-
48
-
-
34249313357
-
Transdermal and buccal delivery of methylxanthines through human tissue in vitro
-
Thakur RA, Michniak BB, Meidan VM,. 2007. Transdermal and buccal delivery of methylxanthines through human tissue in vitro. Drug Dev Ind Pharm 33 (5): 513-521.
-
(2007)
Drug Dev Ind Pharm
, vol.33
, Issue.5
, pp. 513-521
-
-
Thakur, R.A.1
Michniak, B.B.2
Meidan, V.M.3
-
49
-
-
0031816817
-
Effect of cod-liver oil extract on the buccal permeation of ergotamine tartrate
-
Tsutsumi K, Obata Y, Takayama K, Loftsson T, Nagai T,. 1998. Effect of cod-liver oil extract on the buccal permeation of ergotamine tartrate. Drug Dev Ind Pharm 24 (8): 757-762.
-
(1998)
Drug Dev Ind Pharm
, vol.24
, Issue.8
, pp. 757-762
-
-
Tsutsumi, K.1
Obata, Y.2
Takayama, K.3
Loftsson, T.4
Nagai, T.5
-
50
-
-
0034690936
-
Combined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [ d -Ala2, d -Leu5]enkephalin from a cubic phase of glyceryl monooleate
-
Lee J, Kellaway IW,. 2000. Combined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [ d -Ala2, d -Leu5]enkephalin from a cubic phase of glyceryl monooleate. Int J Pharm 204 (1-2): 137-144.
-
(2000)
Int J Pharm
, vol.204
, Issue.12
, pp. 137-144
-
-
Lee, J.1
Kellaway, I.W.2
-
51
-
-
84876854160
-
Design and evaluation of lumefantrine-oleic acid self nanoemulsifying ionic complex for enhanced dissolution
-
Patel K, Sarma V, Vavia P,. 2013. Design and evaluation of lumefantrine-oleic acid self nanoemulsifying ionic complex for enhanced dissolution. Daru 21 (1): 27.
-
(2013)
Daru
, vol.21
, Issue.1
, pp. 27
-
-
Patel, K.1
Sarma, V.2
Vavia, P.3
|